Catalysis is a crucial area of research within the IMI framework due to its ability to accelerate chemical reactions, which is essential for drug development and manufacturing. By enhancing the efficiency and selectivity of these reactions, catalysis can significantly reduce the time and cost associated with producing new medicines. This aligns with IMI’s mission to streamline the drug development process and bring innovative treatments to patients more quickly.
